First validation of the gout activity score against gout impact scale in a primary care based gout cohort - 29/04/18
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 3 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | Gout activity score reflects severity of intercritical gout and not of wellbeing during acute gout. |
• | Gout activity score is only weakly influenced by some measures of overall QOL. |
Abstract |
Objectives |
To validate the gout activity score (GAS) against the gout impact scale in a primary care based gout cohort.
Methods |
This was a single-centre cross-sectional study. People with gout who participated in previous research at academic rheumatology, University of Nottingham, UK, and consented for participation in future studies were mailed a questionnaire in September 2015. Those returning completed questionnaires were invited to attend for a study visit at which blood was collected and musculoskeletal examination was performed. The Gout Assessment Questionnaire, which contains the gout impact scale (GIS), and short form (SF) 36v2 questionnaires were completed. The GAS3-step-c score was calculated. Spearman's correlation coefficient was calculated to examine correlation between GAS and SF-36 v2, and GIS. Statistical analyses were performed using PASW v22.
Results |
One hundred and two (93% men) of the 150 participants who were mailed a questionnaire attended the study visit. Their mean (SD) age, body mass index, serum uric acid and GAS were 67.94 (9.93) years, 29.96 (4.57) kg/m2, 5.25 (1.75) mg/dl, and 2.99 (0.74) respectively. There was moderate correlation between GAS and gout concern overall, unmet gout treatment need, and gout concern during an attack components of GIS (r=0.306 to 0.453), but no to poor correlation between GAS and summary scores and scales of SF-36 v2 (r=–0.090 to –0.251).
Conclusion |
This first study to validate GAS against the GIS found moderate correlation. However, this study did not examine the predictive validity of GAS, and prospective studies are needed before GAS can be used widely.
Le texte complet de cet article est disponible en PDF.Keywords : Gout, Disease activity, Quality of life
Plan
Vol 85 - N° 3
P. 323-325 - mai 2018 Retour au numéro
Article précédent
- Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis
- Fausto Salaffi, Marco Di Carlo, Jelena Vojinovic, Angela Tincani, Alberto Sulli, Stefano Soldano, Laura Andreoli, Francesca Dall’Ara, Ruxandra Ionescu, Katarina Simi? Pašali?, Ineta Bal?une, Iván Ferraz-Amaro, Malgorzata Tlustochowicz, Irena Butrimien?, Egle Punceviciene, Natalia Toroptsova, Simeon Grazio, Jadranka Morovi?-Vergles, Pavol Masaryk, Kati Otsa, Miguel Bernardes, Vladimira Boyadzhieva, Maurizio Cutolo
- Is the SCORE chart underestimating the real cardiovascular (CV) risk of patients with psoriatic arthritis? Prevalence of subclinical CV disease detected by carotid ultrasound
- María Paz Martínez-Vidal, Cristina Fernández-Carballido
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?